João José Cerqueira

Emerging MS research: PIRA & prediction models 3:21
Emerging MS research: PIRA & prediction models
João José Cerqueira • 28 Oct 2022
Challenges with stem cell therapy in MS 2:06
Challenges with stem cell therapy in MS
João José Cerqueira • 28 Oct 2022
T-cell response following COVID-19 vaccination in MS patients under treatment 1:48
T-cell response following COVID-19 vaccination in MS patients under treatment
João José Cerqueira • 28 Oct 2022
Long-term results of ocrelizumab in treatment-naive patients with early relapsing MS 4:32
Long-term results of ocrelizumab in treatment-naive patients with early relapsing MS
João José Cerqueira • 28 Oct 2022
Using high-efficacy treatments at initial stages of MS: addressing safety concerns 1:36
Using high-efficacy treatments at initial stages of MS: addressing safety concerns
João José Cerqueira • 28 Oct 2022
The content of VJNeurology is intended for healthcare professionals